The 6 analysts offering 12-month price forecasts for Osmotica Pharmaceuticals PLC have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +83.75% increase from the last price of 5.17.
The current consensus among 6 polled investment analysts is to Buy stock in Osmotica Pharmaceuticals PLC. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Aug 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.